Shandong Cancer Hospital And Institute

We track 1 ClinicalTrials.gov studies led by Shandong Cancer Hospital And Institute. The portfolio skews toward Phase 2 (1 trials).

1 clinical trials sponsored by Shandong Cancer Hospital And Institute.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials by Shandong Cancer Hospital And Institute

Bevacizumab Plus Iparomlimab/Tuvonralimab With Hepatic Artery Infusion Chemotherapy Followed by Stereotactic Body Radiotherapy in Patients With BCLC Stage C Hepatocellular Carcinoma With Thrombus and/or Extrahepatic Oligometastases (BITS-TO-HCC): Study Protocol of a Prospective, Multicenter, Single-Arm, Phase II Study

NCT07062055 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Shandong Cancer Hospital And Institute sponsor?

Shandong Cancer Hospital And Institute currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Shandong Cancer Hospital And Institute research?

Shandong Cancer Hospital And Institute conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Shandong Cancer Hospital And Institute recruiting for clinical trials?

Yes, Shandong Cancer Hospital And Institute currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More